drugset / Trial / NCT02200029
Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption
Phase 3
Completed
75 enrolled
Abbott
Ascent · collabCatalent · collabClinIntel · collabData Map GmbH · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
A research study of an approved drug called Heptral®, ademetionine, to treat adults with intrahepatic cholestasis (a condition where bile cannot flow from the liver to the duodenum) in pre-cirrhotic and cirrhotic states. Experience from clinical studies in subjects with liver disease has shown that ademetionine is effective.
Timeline
- Start
- 2014-06
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ademetionine | Unknown | 500 mg | Intravenous |